His scientific interests lie mostly in Virology, Immunology, Ebola virus, Immune system and Virus. His work on Transmission as part of general Virology research is often related to Order Mononegavirales, thus linking different fields of science. His study looks at the relationship between Immunology and fields such as Disease, as well as how they intersect with chemical problems.
His work on Ebolavirus and Zaire ebolavirus as part of his general Ebola virus study is frequently connected to West africa and Epidemic spread, thereby bridging the divide between different branches of science. In his study, Influenza A virus is inextricably linked to Interferon, which falls within the broad field of Virus. His research integrates issues of Vaccine efficacy, Vaccination, Vector and B cell mediated immunity in his study of Immunity.
His main research concerns Virology, Ebola virus, Immunology, Virus and Antibody. The concepts of his Virology study are interwoven with issues in Immune system, Immunity and DNA vaccination. Gary P. Kobinger interconnects Monoclonal antibody and Glycoprotein in the investigation of issues within Ebola virus.
His work deals with themes such as Viral vector and Microbiology, which intersect with Virus. His work in Antibody addresses issues such as Serotype, which are connected to fields such as Pandemic. His biological study spans a wide range of topics, including Ebola virus infection and Adenoviridae.
His primary areas of study are Ebola virus, Virology, Disease, Intensive care medicine and Immunity. His Ebola virus study combines topics from a wide range of disciplines, such as Viral entry and Cell biology. As part of one scientific family, Gary P. Kobinger deals mainly with the area of Virology, narrowing it down to issues related to the Antibody, and often Vaccination and Virus.
His Virus research is within the category of Immunology. His Disease research is multidisciplinary, incorporating perspectives in Respiratory disease, Lung, Medical history, Outbreak and Transmission. The Immunity study combines topics in areas such as Pathogen, Transcriptome, Small RNA, microRNA and Liver cell.
Gary P. Kobinger focuses on Virology, Ebola virus, Antibody, Vaccination and Immunization. When carried out as part of a general Virology research project, his work on Virus is frequently linked to work in PIKFYVE, therefore connecting diverse disciplines of study. His Virus study frequently draws connections between related disciplines such as Immunity.
His work on Phosphatidylinositol 3,5-bisphosphate as part of general PIKFYVE study is frequently connected to Kinase activity, Viral entry and Cell biology, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Immune system research incorporates elements of ZMapp, Nucleoprotein and Neutralization. His DNA vaccination research is multidisciplinary, incorporating elements of Human morbidity, Influenza A virus and Serotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Taxonomy of the order Mononegavirales: update 2016
Claudio L. Afonso;Gaya K. Amarasinghe;Krisztián Bányai;Yīmíng Bào.
Archives of Virology (2016)
Nanozyme-strip for rapid local diagnosis of Ebola.
Demin Duan;Kelong Fan;Dexi Zhang;Shuguang Tan.
Biosensors and Bioelectronics (2015)
VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
Andrea Marzi;Shelly J. Robertson;Elaine Haddock;Friederike Feldmann.
A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani;Darryl Falzarano;Emma L. Reuschel;Colleen Tingey.
Science Translational Medicine (2015)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin;Marnie L. Fusco;Zachary A. Bornholdt;Xiangguo Qiu.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.
Hugues Fausther-Bovendo;Gary P Kobinger.
Human Vaccines & Immunotherapeutics (2014)
Transmission of Ebola Viruses: What We Know and What We Do Not Know
Michael T. Osterholm;Kristine A. Moore;Nicholas S. Kelley;Lisa M. Brosseau.
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
Gary P. Kobinger;Heinz Feldmann;Heinz Feldmann;Yan Zhi;Gregory Schumer.
Transmission of Ebola virus from pigs to non-human primates
Hana M. Weingartl;Hana M. Weingartl;Carissa Embury-Hyatt;Charles Nfon;Anders Leung.
Scientific Reports (2012)
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus
Qihui Wang;Huabing Yang;Huabing Yang;Xiaoqing Liu;Lianpan Dai.
Science Translational Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: